- Title
- Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke
- Creator
- Alexandrov, Andrei V.; Tsivgoulis, Georgios; Köhrmann, Martin; Katsanos, Aristeidis H.; Soinne, Lauri; Barreto, Andrew D.; Rothlisberger, Travis; Sharma, Vijay K.; Mikulik, Robert; Muir, Keith W.; Levi, Christopher R.; Molina, Carlos A.; Saqqur, Maher; Mavridis, Dimitris; Psaltopoulou, Theodora; Vosko, Milan R.; Fiebach, Jochen B.; Mandava, Pitchaiah; Kent, Thomas A.; Alexandrov, Anne W.; Schellinger, Peter D.
- Relation
- Therapeutic Advances in Neurological Disorders Vol. 12
- Publisher Link
- http://dx.doi.org/10.1177/1756286419860652
- Publisher
- Sage
- Resource Type
- journal article
- Date
- 2019
- Description
- Background: Results of our recently published phase III randomized clinical trial of ultrasound-enhanced thrombolysis (sonothrombolysis) using an operator-independent, high frequency ultrasound device revealed heterogeneity of patient recruitment among centers. Methods: We performed a post hoc analysis after excluding subjects that were recruited at centers reporting a decline in the balance of randomization between sonothrombolysis and concurrent endovascular trials. Results: From a total of 676 participants randomized in the CLOTBUST-ER trial we identified 52 patients from 7 centers with perceived equipoise shift in favor of endovascular treatment. Post hoc sensitivity analysis in the intention-to-treat population adjusted for age, National Institutes of Health Scale score at baseline, time from stroke onset to tPA bolus and baseline serum glucose showed a significant (p < 0.01) interaction of perceived endovascular equipoise shift on the association between sonothrombolysis and 3 month functional outcome [adjusted common odds ratio (cOR) in centers with perceived endovascular equipoise shift: 0.22, 95% CI 0.06–0.75; p = 0.02; adjusted cOR for centers without endovascular equipoise shift: 1.20, 95% CI 0.89–1.62; p = 0.24)]. After excluding centers with perceived endovascular equipoise shift, patients randomized to sonothrombolysis had higher odds of 3 month functional independence (mRS scores 0–2) compared with patients treated with tPA only (adjusted OR: 1.53; 95% CI 1.01–2.31; p = 0.04). Conclusion: Our experience in CLOTBUST-ER indicates that increasing implementation of endovascular therapies across major academic stroke centers raises significant challenges for clinical trials aiming to test noninterventional or adjuvant reperfusion strategies.
- Subject
- endovascular; equipoise shift; intracranial hemorrhage; mechanical thrombectomy; outcome; recanalization; sonothrombolysis; stroke; ultrasound-enhanced thrombolysis
- Identifier
- http://hdl.handle.net/1959.13/1412858
- Identifier
- uon:36545
- Identifier
- ISSN:1756-2856
- Rights
- This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
- Language
- eng
- Full Text
- Reviewed
- Hits: 26142
- Visitors: 26501
- Downloads: 422
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 545 KB | Adobe Acrobat PDF | View Details Download |